OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
Jingjing Li, Xuan-Fu Xu
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1527-1540
Open Access | Times Cited: 10
Jingjing Li, Xuan-Fu Xu
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1527-1540
Open Access | Times Cited: 10
Showing 10 citing articles:
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
Amin Kamrani, Hadi Nasiri, Ali Hassanzadeh, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Amin Kamrani, Hadi Nasiri, Ali Hassanzadeh, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?
Chen Fu, Weiwei Tong, Lifeng Yu, et al.
Pharmacological Research (2024) Vol. 203, pp. 107160-107160
Open Access | Times Cited: 8
Chen Fu, Weiwei Tong, Lifeng Yu, et al.
Pharmacological Research (2024) Vol. 203, pp. 107160-107160
Open Access | Times Cited: 8
Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access
Immunotherapy Complications
Alexa Meara, Jaclyn Zois, Jason J. Bischof
Emergency Medicine Clinics of North America (2025)
Closed Access
Alexa Meara, Jaclyn Zois, Jason J. Bischof
Emergency Medicine Clinics of North America (2025)
Closed Access
System biology analysis to develop diagnostic biomarkers, monitoring pathological indexes, and novel therapeutic approaches for immune targeting based on maggot bioactive compounds and polyphenolic cocktails in mice with gastric cancer
Elina Kaviani, Fatemeh Hajibabaie, Navid Abedpoor, et al.
Environmental Research (2023) Vol. 238, pp. 117168-117168
Closed Access | Times Cited: 11
Elina Kaviani, Fatemeh Hajibabaie, Navid Abedpoor, et al.
Environmental Research (2023) Vol. 238, pp. 117168-117168
Closed Access | Times Cited: 11
A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance
Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 4
Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 4
JAML inhibits colorectal carcinogenesis by modulating the tumor immune microenvironment
Shiliang Cheng, Meng Li, Chun Guang Li, et al.
In Vitro Cellular & Developmental Biology - Animal (2024) Vol. 60, Iss. 4, pp. 382-396
Closed Access | Times Cited: 1
Shiliang Cheng, Meng Li, Chun Guang Li, et al.
In Vitro Cellular & Developmental Biology - Animal (2024) Vol. 60, Iss. 4, pp. 382-396
Closed Access | Times Cited: 1
Objective Response after Immune Checkpoint Inhibitors in a Chemotherapy-Refractory pMMR/MSS Metastatic Rectal Cancer Patient Primed with Experimental AlloStim® Immunotherapy.
Azriel Hirschfeld, Daniel Gurell, Michael Har-Noy
Research Square (Research Square) (2024)
Open Access
Azriel Hirschfeld, Daniel Gurell, Michael Har-Noy
Research Square (Research Square) (2024)
Open Access
Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy
A. Hirschfeld, Daniel Gurell, Michael Har-Noy
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access
A. Hirschfeld, Daniel Gurell, Michael Har-Noy
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access
Emerging treatment approaches for colorectal cancer treatment resistance
Lloyd Mabonga, Leony Fourie, Abidemi Paul Kappo, et al.
Elsevier eBooks (2024), pp. 107-145
Closed Access
Lloyd Mabonga, Leony Fourie, Abidemi Paul Kappo, et al.
Elsevier eBooks (2024), pp. 107-145
Closed Access
A Phosphatidyl Conjugated Telomerase-Dependent Telomere-Targeting Nucleoside Demonstrates Colorectal Cancer Direct Killing and Immune Signaling
Merve Yılmaz, Sibel Gökşen, Ilgen Mender, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1616-1616
Open Access
Merve Yılmaz, Sibel Gökşen, Ilgen Mender, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1616-1616
Open Access
